Pterostilbene ameliorates pulmonary fibrogenesis and inflammation targeting IL-2...
연구 요약
Pterostilbene ameliorates pulmonary fibrogenesis and inflammation targeting IL-23/ATP6V0D2 pathway: remodel local microenvironment of alveolar epithelial cells and fibroblasts.
International immunopharmacology 학술지에 발표된 이 연구는 Dou JY, Wang CY, Liu SH 외 연구팀이 수행하였습니다.
이 연구는 'Pterostilbene ameliorates pulmonary fibrogenesis and inflammation targeting IL-23/ATP6V0D2 pathway: remodel local microenvironment of alveolar epithelial cells and fibroblasts.'에 대한 과학적 분석을 제공합니다.
핵심 내용
Pterostilbene (PTE) is a natural stilbene compound abundantly found in various small berries such as blueberry and grape, and exhibits multiple health promoting potentials and excellent pharmacological activities, especially antioxidant and anti-inflammatory activities. This study explored the protective effects of PTE on pulmonary fibrogenesis and inflammation and its underlying mechanisms. TGF-β-stimulated BEAS-2B or primary lung fibroblasts (LFs) were cultured with PTE or pirfenidone (PFD). Mice were received intratracheal instillation of bleomycin (BLM) and administered PTE or PFD. IL-23/ATP6V0D2-deficient BEAS-2B were treated with TGF-β or PTE. Primary LFs were stimulated with conditioned medium from TGF-β-primed RLE-6TN (CM) and treated with PTE. In vitro, PTE inhibited TGF-β-induced BEAS-2B cell migration, extracellular matrix (ECM) deposition, epithelial-mesenchymal transition (EMT) and inflammation. In BLM-induced mice, PTE reduced lung index and IL-1β levels in BALF, and improved histopathological changes. PTE inhibited BLM-induced fibrogenesis, EMT, inflammation and immune cell infiltration through blocking IL-23 and activating ATP6V0D2. In TGF-β-induced BEAS-2B, PTE decreased IL-23, increased ATP6V0D2 and ATP levels, and disrupted the interaction between IL-23 and ATP6V0D2. In IL-23-deficient BEAS-2B, PTE further elevated ATP6V0D2 and decreased α-SMA, Vimentin and IL-1β expressions. ATP6V0D2 deficiency attenuated the anti-fibrotic and anti-inflammatory effects of PTE in TGF-β-induced BEAS-2B. PTE also inhibited fibrogenesis, EMT, and inflammation in activated-primary LFs and blocked CM-triggered primary LFs activation by regulating IL-23-ATP6V0D2 axis. In conclusion, PTE ameliorated pulmonary fibrosis targeting IL-23/ATP6V0D2 pathway, especially remodeling the local microenvironment of alveolar epithelial cells and fibroblasts, which might be a novel therapeutic strategy against pulmonary fibrosis.
일반인을 위한 해석
구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.
실천 사항
- 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
- 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
- 이상 반응이 나타나면 즉시 전문가에게 문의하세요
의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41576569)
이 연구와 관련된 약물을 복용 중인가요?
상호작용 체크하러 가기이 정보는 의학 논문의 요약이며, 의사/약사의 전문적 판단을 대체하지 않습니다.